Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in DXCM — Dexcom Inc

CIK 886982 NEW YORK, NY
Back to DXCM Full portfolio

Position in DXCM

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$253,142,785
+$62,002,509 QoQ
Shares Held
3,758,616
+23.5% QoQ
Ownership
0.996%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#18
of 966 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 93% Shared 0% None 7%

Common Shares in DXCM Over Time

Shares Held

Position Value (USD)

Derivatives in DXCM

reported options exposure · as of Jun 30, 2026
CallValue
$4,175,700
CallShares
62,000
PutValue
$19,349,655
PutShares
287,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $6,794,178,953 across 97 Medical Devices names. DXCM ranks #9 (3.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
 16,760,070 $1,520,808,749
2 SYK
Stryker Corp
 2,783,782 $876,445,924
3 BSX
Boston Scientific Corp
 16,954,342 $723,611,313
4 MDT
Medtronic plc
 9,012,210 $705,025,184
5 EW
Edwards Lifesciences Corp
 4,549,113 $411,512,760
6 STE
STERIS plc
 1,363,145 $287,037,441
7 GEHC
GE HealthCare Technologies Inc.
 4,446,565 $284,624,625
8 PEN
Penumbra Inc
 847,104 $267,473,087

All Filings in DXCM

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $19,349,655 287,300
2026-06-30 $4,175,700 62,000
2026-06-30 $253,142,785 3,758,616
2026-03-31 $29,855,120 475,400
2026-03-31 $191,140,276 3,043,635
2026-03-31 $9,231,600 147,000
2025-09-30 $143,347,886 2,130,300
2025-09-30 $25,704,780 382,000
2025-09-30 $17,629,980 262,000
2025-06-30 $16,148,650 185,000
2025-06-30 $217,672,801 2,493,674
2025-06-30 $28,657,307 328,300
2025-03-31 $174,758,342 2,559,062
2025-03-31 $11,923,434 174,600
2025-03-31 $5,804,650 85,000
2024-12-31 $203,732,199 2,619,676
2024-12-31 $2,916,375 37,500
2024-09-30 $1,005,600 15,000
2024-09-30 $2,514,000 37,500
2024-09-30 $151,718,089 2,263,098
2024-06-30 $4,251,750 37,500
2024-06-30 $413,677,246 3,648,591
2024-06-30 $2,040,840 18,000
2024-03-31 $331,055,538 2,386,846
2024-03-31 $3,356,540 24,200
2024-03-31 $416,100 3,000
2023-12-31 $3,747,518 30,200
2023-12-31 $306,973,220 2,473,795
2023-12-31 $818,994 6,600
2023-09-30 $204,560,715 2,192,505
2023-06-30 $339,166,289 2,639,221
2023-06-30 $5,140,400 40,000
2023-03-31 $320,729,063 2,760,622
2022-12-31 $297,706,147 2,628,984
2022-09-30 $757,076 9,400
2022-09-30 $211,196,496 2,622,256
2022-06-30 $180,466,120 2,421,389
2022-06-30 $3,726,500 50,000
2022-03-31 $422,151,855 825,160
2021-12-31 $340,969,155 635,011
2021-12-31 $31,894,830 59,400
2021-09-30 $300,716,125 549,896
2021-09-30 $6,999,808 12,800
2021-06-30 $182,008,750 426,250
2021-06-30 $5,465,600 12,800
2021-03-31 $4,600,192 12,800
2021-03-31 $142,658,421 396,946
2021-03-31 $3,593,900 10,000
2020-12-31 $369,720 1,000
2020-12-31 $9,723,636 26,300

Report a Problem

Category
Description
Email (optional, for follow-up)